Hoechst Roussel Vet Announces FDA Approval Of Dewormer Use

Hoechst Roussel Vet announced today that FDA approval of a new use indication for its dewormer will help eliminate a persistent parasite problem. The FDA's approval that Panacur (10% fedbendazole) Oral Paste can now treat all stages of encysted cyathostomes, or small strongyle larvae, means Panacur is the only deworming product that can make this claim in the equine health

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners